LONG BEACH, Calif. - (Business Wire) Obagi Medical Products, Inc. (Nasdaq: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Company management will present a corporate overview at Baird
’s Growth Stock Conference to be held May 13-15, 2008, at The Four Seasons Hotel in Chicago, Ill.
The presentation will take place at 12:40 p.m. (EDT) on Wednesday, May 14, 2008. A live webcast of the presentation will be available via the Internet by visiting the Investors section of the Company's Web site at www.obagi.com. An archived presentation will be available on the web site for 30 days.
About Obagi Medical Products, Inc.
Obagi Medical Products develops and commercializes skin health products for the dermatology, plastic surgery, and related aesthetic markets. Using its Penetrating Therapeutics™ technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including chloasma, melasma, senile lentigines, acne vulgaris and sun damage. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm™, 1988; Obagi-C Rx™ (the first and only prescription-strength vitamin C and hydroquinone system), 2004; Obagi Professional-C™ (a line of highly stable vitamin C serums), 2005; Obagi Nu-Derm™ Condition and Enhance for use with cosmetic procedures to enhance patient outcomes and satisfaction, 2006; Obagi ELASTIderm™ eye treatment and Obagi CLENZIderm M.D.™ acne therapeutic systems, 2007; a formulation of CLENZIderm M.D.™ Systems for normal to dry skin, June 2007; and ELASTIderm™ Décolletage System, January 2008. Obagi's products are only available through physicians. Visit www.obagi.com for information.
Obagi Medical Products, Inc.
Stephen A. Garcia, Chief Financial Officer, 562-628-1007
or
Investors:
ICR, Inc.
Ina McGuinness/Lena Adams, 310-954-1100
